文献
J-GLOBAL ID:201702235651799905
整理番号:17A0588621
プロテアーゼ活性化型受容体2のアロステリック調節に関する構造的知見
Structural insight into allosteric modulation of protease-activated receptor 2
著者 (28件):
CHENG Robert K. Y.
(Heptares Therapeutics Ltd, Hertfordshire, GBR)
,
FIEZ-VANDAL Cedric
(Heptares Therapeutics Ltd, Hertfordshire, GBR)
,
SCHLENKER Oliver
(Heptares Therapeutics Ltd, Hertfordshire, GBR)
,
BROWN Giles A.
(Heptares Therapeutics Ltd, Hertfordshire, GBR)
,
COOKE Robert M.
(Heptares Therapeutics Ltd, Hertfordshire, GBR)
,
DORE Andrew S.
(Heptares Therapeutics Ltd, Hertfordshire, GBR)
,
JAZAYERI Ali
(Heptares Therapeutics Ltd, Hertfordshire, GBR)
,
PRIHANDOKO Rudi
(Heptares Therapeutics Ltd, Hertfordshire, GBR)
,
RAPPAS Mathieu
(Heptares Therapeutics Ltd, Hertfordshire, GBR)
,
TEHAN Benjamin
(Heptares Therapeutics Ltd, Hertfordshire, GBR)
,
WIGGIN Giselle
(Heptares Therapeutics Ltd, Hertfordshire, GBR)
,
ZHUKOV Andrei
(Heptares Therapeutics Ltd, Hertfordshire, GBR)
,
MARSHALL Fiona H.
(Heptares Therapeutics Ltd, Hertfordshire, GBR)
,
EDMAN Karl
(AstraZeneca, Moelndal, SWE)
,
GESCHWINDNER Stefan
(AstraZeneca, Moelndal, SWE)
,
HERMANSSON Nils-Olov
(AstraZeneca, Moelndal, SWE)
,
JOHANSSON Patrik
(AstraZeneca, Moelndal, SWE)
,
SNIJDER Arjan
(AstraZeneca, Moelndal, SWE)
,
SUNDSTROEM Linda
(AstraZeneca, Moelndal, SWE)
,
DEKKER Niek
(AstraZeneca, Moelndal, SWE)
,
AGGELER Birte
(Bio-techne, Minnesota, USA)
,
LEONG Louis
(Bio-techne, Minnesota, USA)
,
BROWN Dean G.
(AstraZeneca R&D, Massachusetts, USA)
,
DUMELIN Christoph E.
(X-Chem Inc., Massachusetts, USA)
,
SOUTTER Holly
(X-Chem Inc., Massachusetts, USA)
,
TROAST Dawn
(X-Chem Inc., Massachusetts, USA)
,
GREBNER Christoph
(AstraZeneca, Moelndal, SWE)
,
THORNTON Peter
(AstraZeneca, Cambridge, GBR)
資料名:
Nature (London)
(Nature (London))
巻:
545
号:
7652
ページ:
112-115
発行年:
2017年05月04日
JST資料番号:
D0193B
ISSN:
0028-0836
資料種別:
逐次刊行物 (A)
記事区分:
原著論文
発行国:
イギリス (GBR)
言語:
英語 (EN)